Transfusion therapy remains a key component of the treatment of sickle cell disease. Given that blood groups vary depending on an individual’s geographic origin, transfusion therapy can...

Major sickle cell disease (primarily affecting SS, SC, and SB° individuals) is a major public health issue in France due to its high incidence: more than 400 newborns with this genetic...

Although the vulnerability of incarcerated individuals is now widely recognized (in terms of employment, health, housing, etc.), there are few systems in place to monitor their health....

Objectives: To estimate the prevalence of men with a prostate-specific antigen (PSA) test, a biopsy, and newly diagnosed prostate cancer (PC), as well as the treatments and their...

Biomonitoring makes it possible to track the presence of environmental pollutants and their effects on the body. It is currently in high demand among the general public. Public health...

Introduction: Sickle cell disease, the most common genetic disorder in France, was identified as a priority in the 2004 Public Health Act, with goals to reduce mortality and improve care...

Neonatal screening officially began in France in 1972. It is organized by the French Association for the Screening and Prevention of Childhood Disabilities (AFDPHE) and operates under...

Introduction: Toxoplasmosis is a widespread foodborne zoonosis that is usually benign. In cases of primary infection during pregnancy, it can lead to fetal complications that are...

Objectives: To describe the annual trends, between 2009 and 2014, in the prevalence of men free of prostate cancer (PC) who had at least one prostate-specific antigen (PSA) test, a...